Global radiotherapy market is forecasted to value over USD 7 billion by 2026 end and register a CAGR of over 4% from the forecast period 2019-2026.
Latest technological advancements, increasing focus of increasing awareness regarding the benefits and growing prevalence of cancer is driving the market. Based on the figures released by WHO, cancer is one of the major life-threatening diseases and it accounted for the deaths of around 9.7 million people worldwide in 2018. The rising usage of particle therapy for the diagnosis of cancer alongside improving reimbursement policy is boosting the market. Emerging markets alongside rising investments of government and private sectors are fueling the market growth. Improvements and further amendments in image-guided radiotherapy are propelling the market.
The market is classified into product type, type, application, end-user, and region. In terms of type, the market is segmented into radiotherapy, internal beam radiotherapy, systemic radiotherapy, and external beam radiotherapy. External beam radiotherapy is expected to dominate the growth of the market. The precision and accuracy offered by external beam radiotherapy for targeting tumour is better than other methods, which is the primary reason for segment proliferation. In addition, external beam radiotherapy offers less risk of exposure to radiation. Due to these factors, end-users have opted for external beam radiotherapy thus inflating the market.
Based on product type, external beam radiotherapy is expected to achieve the highest CAGR. Less maintenance and equipment costs of linear accelerators alongside precise radiation offered by cyberknife is expected to bolster the market. The 360-degree radiation treatment offered by tomotherapy is adding further growth opportunities thus spurring the market.
In terms of application, prostate cancer segment of external beam radiotherapy is expected to showcase significant growth over the forecast period. Minimally long-term risks associated with external beam radiotherapy coupled with the rising cases of prostate cancer is driving the growth of the market. In addition, the growing adoption of external beam radiation therapy (EBRT) systems for the treatment of breast cancer is expected to expand the market.
On the basis of end-user, hospitals are expected to hold the major market share. The rising cases of cancer have resulted in hospitals demanding more deployment of advanced radiotherapy equipment which has stimulated the market. The rapid expansion of hospitals in developed economies alongside favorable government initiatives aimed towards hospitals inculcating more advanced radiotherapy systems is boosting the market.
In terms of regions, North America dictates the market growth. The easy accessibility, high adoption of advanced diagnostic equipment and rising healthcare expenditure in countries like Canada and the US are stimulating the market in the region. Asia-Pacific region is expected to showcase exponential growth during the forecast period. Rapidly improving healthcare infrastructure alongside growing per capita income in emerging economies like China, Japan and India are bolstering the market in the region. In addition, favorable policies launched by the governments of these countries are expected to boost the market growth in the region.
Major players of the market are Hitachi Ltd., IsoRay Medical, Inc, Ion Beam Applications SA, Provision Healthcare, Varian Medical Systems, Inc, Mevion Medical Systems, Inc, Panacea Medical Technologies Pvt.Ltd, Accuray Incorporated and Elekta AB.
Competitive Landscape:
● Varian Medical Systems in 2017, opened its center in Jundiai, Brazil. The move will increase the access to advanced radiotherapy equipment and treatment across Brazil
● Varian Medical Systems launched an innovative treatment platform called Halcyon Treatment System. The system eases treatment delivery with increased speed and high-quality plans
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=2347&page=requestsample
Global Radiotherapy Market Segmentation
By Product Type
● External Beam Radiotherapy
▪ Linear Accelerators
▪ Particle Therapy System
▪ Conventional Cobalt-60 Teletherapy Units

● Internal Beam Radiotherapy/Brachytherapy
▪ Seeds
▪ Applicators
▪ Afterloaders
▪ Electronic Brachytherapy Products

● Systemic Radiotherapy
▪ Iobenguane (I-131)
▪ Samarium-153
▪ Rhenium-186

By Type
● External Beam Radiotherapy
▪ Image-Guided Radiotherapy
▪ 3d Conformal Radiotherapy
▪ Intensity-Modulated Radiotherapy
▪ Stereotactic Therapy
▪ Particle Therapy

● Internal Beam Radiotherapy
▪ Low-Dose-Rate Brachytherapy
▪ High-Dose-Rate Brachytherapy
▪ Pulsed-Dose-Rate Brachytherapy

● Systemic Radiotherapy
▪ Intravenous Radiotherapy
▪ Oral Radiotherapy
▪ Instillation Radiotherapy


By Application
● External Beam Radiation Therapy
▪ Prostate Cancer
▪ Breast Cancer
▪ Lung Cancer
▪ Head and Neck Cancer
▪ Colorectal Cancer
▪ Other Cancers

● Internal Beam Radiotherapy/Brachytherapy
▪ Prostate Cancer
▪ Gynecological Cancer
▪ Breast Cancer
▪ Cervical Cancer
▪ Penile Cancer
▪ Other Cancers

By End User
● Hospital
● Independent Radiotherapy Centers

By Region:
● North America
● Europe
● Asia Pacific
● Latin America
● Rest of the World
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=2347&page=askfordiscount

FutureWise Key Takeaways
● Growth Prospects
● SWOT Analysis
● Key Trends
● Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global radiotherapy market by type, by product type, by application, by end-user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Limitations and Assumptions
2.4.1 Limitations
2.4.2 Assumptions

3 Executive Summary
4 Premium Insights
4.1 Radiotherapy Market Overview
4.2 Europe: External Radiotherapy Market, By Type, 2019
4.3 Internal Beam Radiotherapy/Brachytherapy Market, By Product Type
4.4 External Beam Radiotherapy Market, By Application
4.5 Regional Analysis: Radiotherapy Market, By End User
4.6 Radiotherapy Market, By Country

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Technological Advancements
5.2.1.2 Rising Prevalence of Cancer
5.2.1.3 Increasing Number of Conferences and Symposia Focusing on Spreading Awareness About the Benefits of Radiotherapy
5.2.1.4 Growing Use of Particle Therapy for Cancer Treatment
5.2.2 Restraints
5.2.2.1 Lack of Adequate Healthcare Infrastructure
5.2.2.2 Shortage of Trained Personnel
5.2.2.3 Affordability and Accessibility of Treatment
5.2.2.4 Complex Nature of Radiotherapy
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Growing Government and Private Investments to Meet the Increasing Demand for Cancer Treatment
5.2.3.3 Improving Reimbursement Scenario
5.2.4 Challenges
5.2.4.1 Difficulties in Visualizing Tumors During Radiotherapy Procedures
5.2.4.2 Risk of Radiation Exposure
5.3 Industry Trends
5.3.1 Growing Adoption of Pencil-Beam Scanning
5.3.2 Growing Number of Collaborations and Acquisitions

6 Radiotherapy Market, By Product Type
6.1 Introduction
6.2 External Beam Radiotherapy
6.2.1 Linear Accelerators
6.2.1.1 Conventional Linear Accelerators
6.2.1.1.1 Lower Equipment and Maintenance Cost Will Drive the Market for Conventional Linacs
6.2.1.2 Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
6.2.1.2.1 Automation and Real-Time Tracking Features Have Ensured Demand for Stereotactic Advanced Linac
6.2.1.2.2 Gamma Knife
6.2.1.2.2.1 The Gamma Knife System is Considered A Gold Standard for Brain Tumor Treatment
6.2.1.2.3 Cyberknife
6.2.1.2.3.1 Cyberknife Offers A Precise Radiation Delivery Method With Specialized Tracking and Robotic Correction Capabilities
6.2.1.2.4 Tomotherapy
6.2.1.2.4.1 360-Degree (Helical) Radiation Treatment With Tomotherapy is Adding Growth Opportunities to This Segment
6.2.2 Particle Therapy Systems
6.2.2.1 Cyclotrons
6.2.2.1.1 Leading Players in the Particle Therapy Market Mainly Manufacture Cyclotrons
6.2.2.2 Synchrotrons
6.2.2.2.1 Increasing Investment for the Development of Synchrotron Facilities are Contributing to Market Growth
6.2.2.3 Synchrocyclotrons
6.2.2.3.1 High Space Requirements of Synchrocyclotrons are Limiting Its Widespread Adoption
6.2.3 Conventional Cobalt-60 Teletherapy Units
6.2.3.1 High Cost and Risk of Radiation Exposure With Cobalt-60 Radioisotopes Have Hindered the Growth of This Segment
6.3 Internal Beam Radiotherapy/Brachytherapy
6.3.1 Seeds
6.3.1.1 Adverse Side-Effects Associated With Seeds Limit Their Adoption
6.3.2 Applicators
6.3.2.1 Manual Applicators Pose A High Risk of Radiation Exposure to the Patients and Staff
6.3.3 Afterloaders
6.3.3.1 Modern Afterloaders Offer Proper Positioning and Better Control of Isotopes Inside the Patient Body
6.3.4 Electronic Brachytherapy Products
6.3.4.1 Electronic Brachytherapy Requires Low Amount of Shielding Than Alternatives
6.4 Systemic Radiotherapy
6.4.1 Iobenguane (I-131)
6.4.1.1 Increasing Incidence of Thyroid Cancer is Driving the Growth of This Segment
6.4.2 Samarium-153
6.4.2.1 Samarium-153 has Wide Applications for Bone Metastasis
6.4.3 Rhenium-186
6.4.3.1 Lack of Insurance Coverage With the Use of Rhenium-186 Restricting Its Growth
6.4.4 Other Systemic Radiotherapy Products

7 Radiotherapy Market, By Type
7.1 Introduction
7.2 External Beam Radiotherapy
7.2.1 Image-Guided Radiotherapy
7.2.1.1 Image-Guided Radiotherapy is Widely Used to the Treatment of Deep-Seated Tumors
7.2.2 3d Conformal Radiotherapy
7.2.2.1 Multiple Beams With 3d-Crt Allow Precise Radiation Conforming to the Tumor Size and Shape
7.2.3 Intensity-Modulated Radiotherapy
7.2.3.1 Volumetric Arc Therapy
7.2.3.1.1 Advancements in the Vmat Technology Driving Its Widespread Adoption
7.2.3.2 Tomotherapy
7.2.3.2.1 Minimal Exposure to Normal Tissues – A Major Advantage of Tomotherapy
7.2.4 Stereotactic Therapy
7.2.4.1 Stereotactic Therapy Offers A Minimally Invasive Alternative to Ablation Surgeries
7.2.5 Particle Therapy
7.2.5.1 Particle Therapy is Increasingly Being Adopted as A Primary Mode of Treatment for Various Cancer Types
7.3 Internal Beam Radiotherapy
7.3.1 Low-Dose-Rate Brachytherapy
7.3.1.1 Lower Risk of Radiation Exposure to the Surrounding Tissues With Ldr Supporting Market Growth
7.3.2 High-Dose-Rate Brachytherapy
7.3.2.1 Better Patient Care With HDR is Driving Its Widespread Adoption
7.3.3 Pulsed-Dose-Rate Brachytherapy
7.3.3.1 Pulsed-Dose Rate Brachytherapy Combines the Advantages of HDR and Ldr Brachytherapy
7.4 Systemic Radiotherapy
7.4.1 Intravenous Radiotherapy
7.4.1.1 Intravenous Route of Brachytherapy Results in Maximum Bioavailability
7.4.2 Oral Radiotherapy
7.4.2.1 Longer Distribution Time Associated With the Oral Mode of Radiation Delivery Limiting Its Demand
7.4.3 Instillation Radiotherapy
7.4.3.1 Lesser Localization With Instillation Brachytherapy is Limiting Its Widespread Adoption

8 Radiotherapy Market, By Application
8.1 Introduction
8.2 External Beam Radiation Therapy
8.2.1 Prostate Cancer
8.2.1.1 High Incidence of Prostate Cancer Will Drive the Demand for Ebrt
8.2.2 Breast Cancer
8.2.2.1 Adoption of Advanced Ebrt Systems and Increasing Research Will Drive Market Growth
8.2.3 Lung Cancer
8.2.3.1 Radiotherapy Can Be Used as Solo Or Combination Therapy for Lung Cancer
8.2.4 Head and Neck Cancer
8.2.4.1 Benefits of External Radiotherapy Will Support Its Use in Head and Neck Cancer Treatment
8.2.5 Colorectal Cancer
8.2.5.1 Availability of Alternative Therapeutic Options Limits the Growth of This Segment
8.2.6 Other Cancers
8.3 Internal Beam Radiotherapy/Brachytherapy
8.3.1 Prostate Cancer
8.3.1.1 Rapidity and Precision of Brachytherapy in Prostate Cancer Treatment Have Driven Market Growth
8.3.2 Gynecological Cancer
8.3.2.1 Availability of Alternatives Hinders the Adoption of Brachytherapy in Gynecological Cancer Treatment
8.3.3 Breast Cancer
8.3.3.1 Precision and Rapid Treatment Times are Driving the Use of Brachytherapy in Breast Cancer Applications
8.3.4 Cervical Cancer
8.3.4.1 A Combination of Brachytherapy and Chemotherapy is Typically Used for Cervical Cancer Treatment
8.3.5 Penile Cancer
8.3.5.1 Advantages of Brachytherapy in Penile Cancer Treatment Have Driven Its Adoption
8.3.6 Other Cancers

9 Radiotherapy Market, By End User
9.1 Introduction
9.1.1 Hospitals
9.1.1.1 Increasing Number of Small-Footprint Advanced Radiotherapy Products Promoting Their Adoption in Hospitals
9.1.2 Independent Radiotherapy Centers
9.1.2.1 Rising Consolidation of Healthcare Networks is Challenging the Growth of Freestanding Radiotherapy Centers

10 Radiotherapy Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Growing Government Initiatives Boosting the Adoption of Radiotherapy in the Us
10.2.2 Canada
10.2.2.1 Rising Cancer Incidence Driving the Demand for Radiotherapy in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Awareness of Novel and Advanced Radiotherapy Products A Key Factor Contributing to Market Growth
10.3.2 France
10.3.2.1 Growing Government Initiatives Boosting the Adoption of Radiotherapy in France
10.3.3 UK
10.3.3.1 Leading Market Players Focusing on Expanding Their Product Offerings in the Uk
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Presence of A Large Number of Local Manufactures Supporting the Growth of the Radiotherapy Market in China
10.4.2 Japan
10.4.2.1 Rising Prevalence of Cancer is Driving the Adoption of Radiotherapy in Japan
10.4.3 India
10.4.3.1 Shortage of Skilled Radiotherapy Professionals in India is Restraining Market Growth
10.4.4 Rest of Asia Pacific
10.5 Rest of the World

11 Competitive Landscape (Page No. - 173)
11.1 Introduction
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Product Launches and Approvals
11.3.2 Acquisitions
11.3.3 Expansions
11.3.4 Partnerships, Agreements, and Collaborations
11.4 Vendor Dive Overview
11.5 Vendor Inclusion Criteria
11.6 Vendor Dive
11.6.1 Vanguards
11.6.2 Innovators
11.6.3 Dynamic Players
11.6.4 Emerging Companies

12 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, FutureWise View)*
12.1 Accuray Incorporated
12.2 C. R. Bard, Inc.
12.3 Elekta
12.4 Hitachi, Ltd.
12.5 IBA (Ion Beam Applications Sa)
12.6 Isoray Medical, Inc.
12.7 Mevion Medical Systems, Inc.
12.8 Optivus Proton Therapy, Inc.
12.9 Panacea Medical Technologies Pvt. Ltd.
12.10 P-Cure Ltd.
12.11 Provision Healthcare, LLC.
12.12 Sumitomo Heavy Industries, Ltd
12.13 Theragenics Corporation
12.14 Varian Medical Systems, Inc.
12.15 Viewray Inc.
*Details on FutureWise View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com